NPI: 1154759694 · BAKERSFIELD, CA 93304 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 10/18/2013
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 10/18/2013 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 19,554 | $1.37M |
| 2019 | 19,301 | $1.51M |
| 2020 | 16,386 | $1.42M |
| 2021 | 17,691 | $1.56M |
| 2022 | 17,135 | $1.50M |
| 2023 | 14,515 | $1.89M |
| 2024 | 11,053 | $1.52M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 46,358 | 3,699 | $10.71M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 30,530 | 2,041 | $47K |
| A4657 | Syringe, with or without needle, each | 2,254 | 1,170 | $10K |
| J1756 | Injection, iron sucrose, 1 mg | 11,072 | 2,261 | $4K |
| 90674 | 135 | 121 | $4K | |
| J1270 | Injection, doxercalciferol, 1 mcg | 19,871 | 1,542 | $1K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 1,690 | 808 | $195.56 |
| 83970 | 787 | 702 | $149.96 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 29 | 24 | $145.46 |
| 85041 | 849 | 766 | $111.13 | |
| 85048 | 817 | 738 | $101.12 | |
| 82728 | 461 | 384 | $26.42 | |
| 83550 | 339 | 266 | $10.61 | |
| 83540 | 443 | 366 | $8.42 |